Skip to main content
. 2017 May 31;1:PO.17.00029. doi: 10.1200/PO.17.00029

Fig A5.

Fig A5.

Alterations in the MAP kinase pathway. (A) Oncoprint of somatic alterations in MAP kinase pathway genes. 5% of patients harbor a somatic alteration in one of the genes listed. (B) Missense mutations in MAP kinase pathway genes. Known activating hotspot mutations are labeled.